Intractable pyoderma gangrenosum in a Crohn's disease patient on vedolizumab.

JAAD Case Rep

Harvard Medical School, Brigham and Women's Hospital, Boston, Massachusetts; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts; Angiogenesis and Wound Healing Center, Brigham and Women's Hospital, Boston, Massachusetts.

Published: March 2017

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5347515	PMC
http://dx.doi.org/10.1016/j.jdcr.2017.01.012	DOI Listing

Publication Analysis

intractable pyoderma

pyoderma gangrenosum

gangrenosum crohn's

crohn's disease

disease patient

patient vedolizumab

intractable

gangrenosum

crohn's

disease

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!